Autologous Bone Marrow Cell Treatment in Peripheral Atherosclerosis
|ClinicalTrials.gov Identifier: NCT00306085|
Recruitment Status : Unknown
Verified March 2006 by University of Naples.
Recruitment status was: Recruiting
First Posted : March 22, 2006
Last Update Posted : March 22, 2006
|Condition or disease||Intervention/treatment||Phase|
|Peripheral Vascular Diseases||Genetic: Autologous bone marrow cells||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Autologous Bone Marrow Cell Treatment in Patients With Peripheral Atherosclerosis|
|Study Start Date :||April 2005|
|Estimated Study Completion Date :||April 2006|
- Clinical and instrumental indexes of functional impairment of peripheral atherosclerosis.
- Angiographic and laser doppler measurements after six months from treatment.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00306085
|Contact: Heidi Eisele||+39 firstname.lastname@example.org|
|University of Naples||Recruiting|
|Naples, Italy, 80134|
|Contact: Maria Carmela Corbisiero +39081/5665681 email@example.com|
|Study Director:||Vincenzo Sica||University of Naples|